The dilemma of evaluating iron status in dialysis patients-limitations of available diagnostic procedures

G. Sunder-Plassmann, S. Spitzauer, W. Horl
1997 Nephrology, Dialysis and Transplantation  
Key words: rHuEpo; iron status; ferritin; transferrin pathy, one from interstitial nephritis, and one from chronic glomerulonephritis. All patients were treated saturation; hypochromic red blood cells; soluble transferrin receptor; dialysis with i.v. rHuEpo and i.v. iron saccharate for at least 12 months. Iron saccharate ( Ferrivenin, Laevosan, Austria) was given in 10-, 20-or 40-mg doses at the end of each haemodialysis treatment to maintain trans-
doi:10.1093/ndt/12.8.1575 pmid:9269632 fatcat:knwo6fyjezei3nu3allqsexpny